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WELL-POSEDNESS OF A MATHEMATICAL MODEL FOR ALZHEIMER’S
DISEASE
MICHIEL BERTSCH, BRUNO FRANCHI, MARIA CARLA TESI, AND ANDREA TOSIN
Abstract. We consider the existence and uniqueness of solutions of an initial-boundary value
problem for a coupled system of PDE’s arising in a model for Alzheimer’s disease. Apart from
reaction diffusion equations, the system contains a transport equation in a bounded interval for a
probability measure which is related to the malfunctioning of neurons. The main ingredients to
prove existence are: the method of characteristics for the transport equation, a priori estimates
for solutions of the reaction diffusion equations, a variant of the classical contraction theorem,
and the Wasserstein metric for the part concerning the probability measure. We stress that all
hypotheses on the data are not suggested by mathematical artefacts, but are naturally imposed
by modelling considerations. In particular the use of a probability measure is natural from
a modelling point of view. The nontrivial part of the analysis is the suitable combination
of the various mathematical tools, which is not quite routine and requires various technical
adjustments.
1. Introduction
In [3, 4] a macroscopic mathematical model was proposed which describes the onset and evo-
lution of Alzheimer’s disease (AD). This model is meant to mirror the so-called Amyloid Cascade
Hypothesis [11, 15, 21], coupled with the spreading of the disease through neuron-to-neuron trans-
mission (prionoid hypothesis [5, 23]). Alzheimer’s disease (AD) is the prevalent form of late life
dementia. Its global prevalence, about 24 millions in 2011, is expected to double in 20 years [19].
In order to clarify the structure of our equations and the choice of our assumptions, let us
sketch a gist of their biological background. We refer to [3, 4] for a complete description of the
model and an account of the most recent biomedical literature. The model focusses on the role
of the polymer beta-amyloid, in particular its toxic soluble isoform Aβ42. Monomers of Aβ42 are
regularly produced by neurons and successively cleared – among others – by the microglia. In
the last decades, researchers have observed that an imbalance between production and clearance
of Aβ42 (shortly Aβ from now on) is a very early, often initiating factor in AD. Soluble Aβ
diffuses through the microscopic tortuosity of the brain tissue and undergoes an agglomeration
process. Eventually this leads to the formation of long, insoluble fibrils, accumulating in spherical
deposits known as senile plaques that are solid deposits of even larger aggregates of Aβ; nowadays,
plaques are not considered neurotoxic, but are usually abundantly present in the brain of AD-
patients (though they can be present in old brains without any symptom of dementia). Plaques
are clinically observable through medical imaging using a special type of PET (Positron Emission
Tomography) scan.
Below we briefly describe the model. The main purpose of the present paper is to establish its
mathematical well-posedness. Mathematically, our model consists of a transport equation coupled
with a system of nonlinear diffusion equations (a Smoluchowski-type system with diffusion). Due
to the very nature of the biological phenomena we are studying, the main feature of such a system
is that the transport velocity depends on the solution of the Smoluchowski equation, which, in
turn, contains a source term that depends on the solution of the transport equation, so that the two
groups of equations cannot be uncoupled. For an introduction to the use of transport equations
in mathematical models of life sciences, we refer the reader to [18].
Key words and phrases. Transport and diffusion equations; Smoluchowski equations; mathematical models of
Alzheimer’s disease.
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Let us give a less cursory description of the system which we consider, from both a mathemati-
cal and biomedical point of view. We do not enter the biological details and merely mention those
which are related to the structure of our equations. We would like to stress that the equations of
our model involve only functions that have a precise qualitative clinical counterpart in routinely
observable phenomena: the health state of the different brain regions (by means of a PET mea-
suring the cerebral glucose metabolism), the amount of Aβ in the cerebral spinal fluid, and the
Aβ plaques (by means of amyloid-PET scans).
Let Ω ⊆ Rn be a portion of cerebral tissue. The molar concentration of soluble Aβ polymers
of length m at x ∈ Ω and time t ≥ 0 is denoted by um(x, t) (1 ≤ m < N), that of clusters of
oligomers of length greater or equal to N (the plaques) by uN(x, t). We use a parameter a, ranging
from 0 to 1, to describe the degree of malfunctioning of a neuron; a close to 0 stands for “the
neuron is healthy” and a close to 1 for “the neuron is dead”. Given x ∈ Ω and t ≥ 0, f = fx,t
is a probability measure and dfx,t(a) denotes the fraction of neurons at x and time t with degree
of malfunctioning between a and a + da. The progression of AD is mainly determined by the
deterioration rate of the health state of the neurons, v = vx(a, t) ≥ 0. We use the notation v[f ]
to stress its dependence on f :
(1) (v[f ])x(a, t) :=
∫
Ω
(∫
[0,1]
K(x, a, y, b) dfy,t(b)
)
dy + S(x, a, u1(x, t), . . . , uN−1(x, t)).
The term S ≥ 0 in (1) models the action of toxic Aβ oligomers. For example, assuming that
the toxicity of soluble Aβ-polymers is proportional to their total mass and introducing a threshold
value U > 0 for the amount of toxic Aβ needed to damage neurons, a possible choice for S is
(2) S = CS(1− a)
(
N−1∑
m=1
mum(x, t)− U
)+
, where p+ := max{p, 0},
see also [3] for a more detailed discussion.
The integral term in (1) describes the possible propagation of AD through the neural pathway.
Malfunctioning neighbours are harmful for a neuron’s health state, while healthy ones are not:
K(x, a, y, b) ≥ 0 for all x, y ∈ Ω and a, b ∈ [0, 1] and
K(x, a, y, b) = 0 if a > b.
For the sake of simplicity we choose K(x, a, y, b) = Gx(a, b)h(|x− y|), where h(r) is a nonnegative
and decreasing function which vanishes at some r = r0 and satisfies
∫
|y|<r0
h(|y|) dy = 1. For
instance, in [3] the following form of Gx is used: Gx(a, b) = CG(b − a)+, which does not depend
explicitly on x. In the limit r0 → 0, (1) reduces to
(3) (v[f ])x(a, t) =
∫
[0,1]
Gx(a, b) dfx,t(b) + S(x, a, u1(x, t), . . . , uN−1(x, t)).
We shall henceforth use (3) for the deterioration rate v[f ].
In view of the meaning of the rate v, the equation for f is given by
(4) ∂tf + ∂a(fv[f ]) = J [f ].
The term J [f ] represents the onset of AD: we assume that in small (randomly chosen) parts of the
cerebral tissue, concentrated for instance in the hippocampus and described by a characteristic
function χ(x, t), the degree of malfunctioning of neurons randomly jumps to higher values due to
external agents or genetic factors. More precisely, (J [f ])x,t denotes the measure
(5) d(J [f ])x,t(a) := η(t)χ(x, t)
[(∫
[0,1]
P (t, b, a) dfx,t(b)
)
da− dfx,t(a)
]
,
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where the function P (t, b, a) is the probability to jump from state b to state a (which vanishes if
a < b) and η > 0 is the jump frequency. A possible choice is
P (t, b, a) ≡ P (b, a) =
{
2
1−b if b ≤ a ≤
1
2 (1 + b)
0 otherwise.
It is worth stressing that the choice of looking for a measure fx,t comes from the model itself. In
fact, a “healthy brain” would correspond to fx,t(a) = δ(a), where δ is the Dirac measure centred
at the origin.
Now we are ready to write the system of equations for f , u1, · · · , uN :
(6)


∂tf + ∂a (fv[f ]) = J [f ] in Ω× [0, 1]× (0, T ]
ε∂tu1 − d1∆u1 = R1 := −u1
N∑
j=1
a1,juj + F [f ]− σ1u1 in QT = Ω× (0, T ]
ε∂tum − dm∆um = Rm :=
1
2
m−1∑
j=1
aj,m−jujum−j
− um
N∑
j=1
am,juj − σmum in QT (2 ≤ m < N)
ε∂tuN =
1
2
∑
j+k≥N
k, j<N
aj,kujuk in QT .
Here ε > 0 is a small parameter which expresses the existence of two time scales: processes which
determine the dynamics of Aβ (production, aggregation, diffusion, deposition) occur on a much
smaller time scale (hours) than the evolution of the disease (years). The diffusion coefficients dm
depend on the length of the polymer (longer polymers diffuse less); plaques do not diffuse. The
quadratic terms (in ui) model the aggregation of Aβ polymers, according to the Smoluchowski
equations. We refer to [1, 10] for an extensive discussion of the aggregation mechanism and the
choice of the coagulation rates ai,j . The linear terms −σmum model the phagocytic activity of
the microglia and other bulk clearance processes [14].
We stress that system (6) is fully coupled, because the transport equation for f contains a
dependence on u1, . . . , uN−1 in the deterioration rate v[f ], cf. (3). Notice that if S ≡ 0 in (3)
then the equation for f decouples from the rest of the system and may be possibly studied alone
by relying on the results reported in [6, 7]. Nevertheless, the assumption S ≡ 0 is not a minor
issue in the modelling of AD spreading, because it would imply a propagation of the disease due
only to prionic diffusion, which is a controversial topic in the medical literature. For this reason,
in our model we prefer to take into account also the toxic contribution of Aβ oligomers, i.e. S 6= 0
in (3), which requires to study system (6) as a whole.
Aβ monomers are produced by neurons. Their production increases if neurons are damaged,
and a possible choice for the source term F in the equation for u1 is
(7) F [f ](x, t) = CF
∫ 1
0
(µ0 + a)(1 − a) dfx,t(a).
The small constant µ0 > 0 accounts for Aβ production by healthy neurons.
We assume that ∂Ω consists of smooth disjunct boundaries, ∂Ω0 and ∂Ω1, where ∂Ω1 represents
the disjunct union of the boundaries of the cerebral ventricles through which Aβ is removed from
the cerebrospinal fluid (CSF) by an outward flow through the choroid plexus (cf. [14, 22]). In the
present paper we solve system (6) with appropriate initial-boundary conditions:
(8)


fx,0 = (f0)x if x ∈ Ω
ui(x, 0) = u0i(x) if x ∈ Ω, 1 ≤ i ≤ N
∂nui(x, t) = 0 if x ∈ ∂Ω0, t > 0, 1 ≤ i < N
∂nui(x, t) = −γiui(x, t) if x ∈ ∂Ω1, t > 0, 1 ≤ i < N,
where n is the outward pointing normal on ∂Ω.
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In Section 2 we describe the hypotheses on the data and formulate the main result on global
well-posedness. In Section 3 we rewrite the system in terms of the characteristics of the transport
equation for f and show that the new system is equivalent to the original one. We point out that
under our assumptions the characteristics exist in the classical sense. The major difficulty arises
from the strong nonlinearity of the system: the transport equation depends nonlinearly on both
its solution (through an integral operator) and the solution of the Smoluchowski system, which
in turn depends on the solution of the transport equation. In Section 4 we use a contraction
argument to prove local existence and uniqueness; not surprisingly, the metric for the probability
measures f will involve Wasserstein distances. The fact that the Wasserstein distanceW1 depends
on the action of the measures on Lipschitz functions yields a technical difficulty when we try to
apply an iteration argument in order to obtain the local existence of a solution. This difficulty
can be bypassed thanks to an ad hoc formulation of the standard fixed point theorem. Finally,
in Section 5 we prove a priori bounds which imply global existence. In Appendix A we collect
some technical facts about probability measures and Wasserstein distances to make this paper as
self-consistent as possible.
We conclude with some comments.
For more details on the model we refer to [3], which also contains some two-dimensional simula-
tions and qualitative comparison with experimental data. A derivation of the transport equation
for f from a Boltzmann-type kinetic approach is contained in [4].
The macroscopic model which we have briefly described, and in particular the use of the Smolu-
chowski equations to model the aggregation of Aβ, is based on an earlier microscopical model de-
scribed in [1, 10]. The passage from that microscopic aggregation-diffusion model to Smoluchowski
equations with a source term as in (6) is obtained by a two-scale homogenization technique in [8, 9].
For the moment the model deliberately neglects some important aspects of the disease such as
the role of the tau-protein, but in a future paper we shall extend the model and make it more
realistic. Nevertheless, the term G in the deterioration rate for the equation of f can already be
thought of as taking into account a “prionic” model of the spread of the disease, and associated with
the diffusion of the intraneural tau-protein (see, e,g., [13, 23]). Despite the extreme complexity
of AD, mathematically such an extension is doable due to the high degree of flexibility of the
modelling approach. The major difficulty is the lack of both experimental data and detailed
knowledge about the relevant biomedical processes, but fortunately biomedical research on AD
evolves rapidly.
In this context we also mention a recent paper by Hao and Friedman [12], which does take into
account a higher degree of AD’s complexity and contains simulations of medical therapies; the
authors however do not consider AD’s initial stage. A major challenge is how to diagnose AD’s
early stage and develop therapies to slow down its further development.
2. Problem statement and main results
Throughout the paper we set T > 0, N ∈ N, while Ω ⊂ Rn is an open and bounded set with a
smooth boundary ∂Ω, which is the disjunct union of ∂Ω0 and ∂Ω1.
To treat the measures fx,t we introduce a metric space X[0,1]:
Definition 2.1. The space P([0, 1]) of probability measures on [0, 1] endowed with the Wasserstein
distance W1 is denoted by X[0,1].
We refer to [2] for the definition of the Wasserstein distances Wp. By Proposition A.3, X[0,1] is
a complete separable metric space. By Proposition A.7, a sequence (µn)n∈N converges in X[0,1] if
and only if it converges narrowly or weakly∗.
We denote by C([0, T ];X[0,1]) the space of continuous functions from the interval [0, T ] to X[0,1].
Endowed with the distance
max
0≤t≤T
W1((µ1)t, (µ2)t),
also C([0, T ];X[0,1]) is a complete metric space.
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2.1. Hypotheses on the data. Throughout the paper we shall use the following assumptions
on the data (below ∂a, ∇u etc. denote distributional derivatives; C denotes a generic constant):
(H1) ε, CF , µ0, di, σi, γi, ai,j are positive constants (1 ≤ i < N , 1 ≤ j ≤ N);
(H2) u0i ∈ C(Ω) is nonnegative (i = 1, · · · , N), and (f0)x ∈ X[0,1] for a.e. x ∈ Ω;
(H3) χ is the characteristic function of a measurable set Q0 ⊆ QT = Ω × [0, T ]; the function
η ∈ C([0, T ]) is nonnegative;
(H4) for a.e. x ∈ Ω, Gx ∈ C
(
[0, 1]2
)
, Gx(1, b) = 0 for b ∈ [0, 1], and
(9) − C ≤ ∂aGx ≤ 0, |∂bGx| ≤ C in [0, 1]
2;
(H5) S ∈ L∞
(
Ω;C
(
[0, 1]× [0,∞)N−1
))
, S(x, 1, u1, . . . , uN−1) = 0 for ui ≥ 0 and a.e. x ∈ Ω,
and for all compact sets K ⊂ [0,∞)N−1 there exists a constant C(K) such that for a.e.
x ∈ Ω
(10) − C(K) ≤ ∂aS(x, a, u) ≤ 0, |∇uS(x, a, u)| ≤ C(K) for a ∈ [0, 1], u ∈ K;
(H6) P ∈ C([0, T ]× [0, 1]2), P is nonnegative, for all t ∈ [0, T ]
(11)
∫ 1
0
P (t, b, a) da = 1 for b ∈ [0, 1] , P (t, b, a) = 0 if a < b
and there exists L > 0 such that for all a′, a′′, b′, b′′ ∈ [0, 1] and t ∈ [0, T ]
(12)
∣∣P (t, b′, a′)− P (t, b′′, a′′)∣∣ ≤ L (∣∣b′ − b′′∣∣+ ∣∣a′ − a′′∣∣).
2.2. Main result. We introduce some additional notation. Let M(0, 1) be the space of signed
Radon measures on the interval (0, 1). ThenM(0, 1) is the dual of C([0, 1]), and µ : Ω× (0, T )→
M(0, 1) is said to be weakly∗ measurable if for any ρ ∈ C([0, 1]) the map
(13) (x, t) 7→
∫
ρ(a)dµx,t(a)
is measurable in Ω× (0, T ). We say that
f ∈ L(Ω;C([0, T ];X[0,1]))
if f ∈ C([0, T ];X[0,1])) for a.e. x ∈ Ω and f is weakly
∗ measurable as a function from Ω× (0, T )
in M(0, 1). In particular, if f ∈ L(Ω;C([0, T ];X[0,1])), then, by the Fubini-Tonelli Theorem, for
all ψ ∈ C([0, 1]× Ω× [0, T ])
x 7→
∫ T
0
(∫
ψ(a, x, t) dfx,t(a)
)
dt belongs to L∞(Ω).
Definition 2.2. A (N + 1)-ple (f, u1, · · · , uN) is called a solution of problem (6)-(8) in [0, T ] if
(i) f ∈ L(Ω;C([0, T ];X[0,1]));
(ii) ui ∈ C(QT ) and ui ≥ 0 in QT for 1 ≤ i ≤ N ;
(iii) the first equation in (6) is satisfied in a weak sense: for a.e. x ∈ Ω∫ τ
0
(∫
(∂tφ+ vx∂aφ) dfx,t +
∫
φdJx,t
)
dt =
∫
φ(·, τ) dfx,τ −
∫
φ(·, 0) d(f0)x
for all τ ∈ [0, T ] and φ ∈ C1([0, 1]× [0, T ]), where the function v is defined by (3) and the
signed measure J by (5);
(iv) if 1 ≤ i < N , ui ∈ L2([0, T ];H1(Ω)) and
di
∫ T
0
[∫
Ω
∇ui(x, s) · ∇ψ(x, s)dx + γi
∫
∂Ω1
ui(x, s)ψ(x, s)dσ(x)
]
ds
= ε
∫∫
QT
uiψt + ε
∫
Ω
u0iψ(x, 0) dx+
∫∫
QT
Riψ
(14)
for all ψ ∈ H1([0, τ ];H1(Ω)), ψ(x, τ) = 0, where Ri is defined as in (6) and F (which is
part of R1) by (7);
(v) ∂tuN ∈ C(QT ), uN(·, 0) = u0N in Ω, and the equation for uN in (6) is satisfied in QT .
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Remark 2.3. (a) It follows from (5) and (H6) that, for a.e. x ∈ Ω,
∫
dJx,t = 0 for t ∈ [0, T ]. (b)
The concept of weak solution of the first order transport equation, defined in Definition 2.2(iii),
needs some explanation. It follows from (9)-(10) that, for a.e. x ∈ Ω, v is uniformly Lipschitz
continuous with respect to a:
(15) ∂avx(a, t) =
∫
[0,1]
∂aG(x, a, b) dfx,t(b) + ∂aS(x, a, u1(x, t), . . . , uN−1(x, t)) ≤ 0.
In particular it follows from (H4−5) that, for a.e. x ∈ Ω, vx(1, t) = 0 for t ∈ [0, T ] and vx(a, t) ≥ 0
for a ∈ [0, 1] and t ∈ [0, T ]. This implies that formally the “flux” fv vanishes at a = 1, a condition
which is made precise by the choice of continuous test functions φ(x, a, t) without any restriction
at a = 1. Since v ≥ 0 at a = 0, characteristics (see the next section) “enter the domain [0, 1]” at
a = 0; so we need a boundary condition at a = 0 which, according to Definition 2.2(iii), is again
the no-flux condition. Actually this is imposed by the condition that fx,τ is a probability measure
in [0, 1]: choosing φ ≡ 1 it follows from Definition 2.2(iii) and Remark 2.3(a) that for a.e. x ∈ Ω∫
dfx,τ =
∫
d(f0)x = 1 for τ ∈ (0, T ].
The main result of the paper is the following well-posedness result.
Theorem 2.4. Let Ω ⊂ Rn be an open and bounded set with a smooth boundary ∂Ω, which is the
disjunct union of ∂Ω0 and ∂Ω1. Let T > 0 and N ∈ N, and let hypotheses (H1−6) be satisfied.
Then problem (6)-(8) has a unique solution in [0, T ] in the sense of Definition 2.2.
3. The characteristics
Let f ∈ L(Ω;C([0, T ];X[0,1])) and ui ∈ C(QT ), and let v[f ] be defined by (3). By the Lipschitz
continuity of a 7→ vx(a, t) (see Remark 2.3(b)), for a.e. x ∈ Ω the problem for the characteristic
issued from y ∈ [0, 1],
(16)
{
∂tAx(y, t) = vx(Ax(y, t), t) for 0 < t ≤ T
Ax(y, 0) = y
has a unique solution which satisfies
(17)
{
0 ≤ Ax(y1, t) < Ax(y2, t) ≤ Ax(1, t) = 1 if 0 ≤ y1 < y2 ≤ 1, 0 ≤ t ≤ T
Ax(y, t1) ≤ Ax(y, t2) if y ∈ [0, 1], 0 ≤ t1 ≤ t2 ≤ T .
Observe that, for a.e. x ∈ Ω, the function y 7→ Ax(y, t) is continuous and
(18) ∂yAx(y, t) = exp
(∫ t
0
∂avx(Ax(y, s), s) ds
)
> 0 for all t ∈ [0, T ].
In particular for a.e. x ∈ Ω the function y 7→ Ax(y, t) is injective for all t ∈ [0, T ].
Below we shall reformulate problem (6)-(8) in terms of the characteristics, but before doing so
we prove the following result.
Proposition 3.1. Let f ∈ L(Ω;C([0, T ];X[0,1])) and ui ∈ C(QT ). Let v[f ] and J [f ] be defined by
(3) and (5). Let, for a.e. x ∈ Ω, Ax(y, t) be the solution of (16) for any y ∈ [0, 1]. If f satisfies
(4) in the sense of Definition 2.2 (iii), then, for a.e. x ∈ Ω,
(19) supp fx,t, supp Jx,t ⊆ [Ax(0, t), 1] for t ∈ (0, T ].
Proof. Ax is well defined for a.e. x ∈ Ω. We fix such x and also τ ∈ (0, T ]. Let h ∈ C1(R) be
nondecreasing and satisfy h ≡ 0 in (−∞, 0] and h ≡ 1 in [1,∞). Let δ > 0 and set for a.e. x ∈ Ω
hδ(s) = h(s/δ) for s ∈ R; ψδ(a, t) = hδ(Ax(0, t)− a) for a ∈ [0, 1], t ∈ [0, T ].
Then ψδ is of class C
1 and
∂aψδ = −
1
δ
h′
(
Ax(0, t)− a
δ
)
, ∂tψδ =
1
δ
vx(Ax(0, t), t)h
′
(
Ax(0, t)− a
δ
)
.
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We use ψδ as a test function in Definition 2.2 (iii). Since Ax(0, 0) = 0, ψδ(a, 0) = 0 if a ≥ 0
and
∫
ψδ(·, 0) d(f0)x = 0. Therefore the test function relation implies that
(20)
∫
ψδ(·, τ) dfx,τ −
∫ τ
0
(∫
ψδ dJx,t
)
dt→ 0 as δ → 0
if we prove that
(21)
∫ τ
0
(∫
(∂tψδ + vx∂aψδ) dfx,t
)
dt→ 0 as δ → 0.
To prove (21) we observe that
|∂tψδ + vx∂aψδ| =
∣∣∣∣vx(Ax(0, t), t)−vx(a, t)δ h′
(
Ax(0, t)−a
δ
)∣∣∣∣ ≤ C sup
s∈R
|sh′(s)|
for some constant C which does not depend on δ, whence
∣∣∣∣
∫ τ
0
(∫
(∂tψδ + vx∂aψδ) dfx,t
)
dt
∣∣∣∣
≤ C
∫ τ
0
(∫
dfx,t (Ax(0, t)− δ, Ax(0, t)) ∩ [0, Ax(0, t))
)
dt.
(22)
Here and in the following, the symbol denotes the restriction of a measure to a measurable
subset, see [16, Definition 1.8]. Since
⋂
δ>0
(Ax(0, t)− δ, Ax(0, t)) ∩ [0, Ax(0, t)) = ∅ and
∣∣∣∣
∫
dfx,t (Ax(0, t)− δ, Ax(0, t)) ∩ [0, Ax(0, t))
∣∣∣∣ ≤ 1 for t ∈ [0, τ ],
(21) follows from (22) and the Dominated Convergence Theorem.
By (20) and the Dominated Convergence Theorem,
(23)
∫
dfx,τ [0, Ax(0, τ)) =
∫ τ
0
(∫
dJx,t [0, Ax(0, t))
)
dt .
It follows from (5), the Fubini-Tonelli Theorem and (11) that
∫
dJx,t(a) [0, Ax(0, t))
= η(t)χ(x, t)
[∫ (∫ Ax(0,t)
0
P (t, b, a) da
)
dfx,t(b)−
∫
dfx,t(a) [0, Ax(0, t))
]
= ηχ
[∫ (∫ Ax(0,t)
b
P (t, b, a) da
)
dfx,t(b) [0, Ax(0, t))−
∫
dfx,t(a) [0, Ax(0, t))
]
≤ηχ
[∫
dfx,t(b) [0, Ax(0, t))−
∫
dfx,t(a) [0, Ax(0, t))
]
= 0.
Combined with (23), this implies (19). 
We now reformulate the original problem in terms of the characteristics. Specifically, we shall
see below that the measure f can be obtained by transporting along the characteristics a suitable
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measure g (i.e., f is the push forward of g through A, cf. Definition A.1), which satisfies:
(24)


∂tAx(y, t)=
∫
Gx(Ax(y, t), Ax(ξ, t)) dgx,t(ξ)+S(x,Ax(y, t), u1, . . . , uN−1)
∂tgx,t(y) = ηχ
[
∂yAx(y, t)
∫
P (t, Ax(ξ, t), Ax(y, t)) dgx,t(ξ)−gx,t(y)
]
ε∂tu1−d1∆u1= R˜1 := −u1
N∑
j=1
a1,juj−σ1u1 + CF
∫
(µ0+Ax(ξ, t))(1−Ax(ξ, t)) dgx,t(ξ)
ε∂tum − dm∆um = R˜m :=
1
2
m−1∑
j=1
aj,m−jujum−j − um
N∑
j=1
am,juj − σmum
ε∂tuN =
1
2
∑
j+k≥N
k, j<N
aj,kujuk,
where x ∈ Ω, y ∈ [0, 1], t ∈ (0, T ] and 2 ≤ m < N , with initial-boundary conditions
(25)


gx,0(y) = (f0)x(y), Ax(y, 0) = y if x ∈ Ω, 0 ≤ y ≤ 1
ui(x, 0) = u0i(x) if x ∈ Ω, 1 ≤ i ≤ N
∂nui(x, t) = 0 if x ∈ ∂Ω0, t ∈ (0, T ], 1 ≤ i < N
∂nui(x, t) = −γiui(x, t) if x ∈ ∂Ω1, t ∈ (0, T ], 1 ≤ i < N.
Definition 3.2. The (N + 2)-ple (A, g, u1, · · · , uN) is called a solution of problem (24)-(25) in
[0, T ] if
(i) g ∈ L(Ω;C([0, T ];X[0,1]));
(ii) A, ∂tA ∈ L
∞(Ω;C([0, 1]× [0, T ]; [0, 1]));
(iii) ui ∈ C(QT ) and ui ≥ 0 in QT for 1 ≤ i ≤ N ;
(iv) for a.e. x ∈ Ω, Ax satisfies (24)1 and Ax(y, 0) = y for y ∈ [0, 1];
(v) equation (24)2 for g is satisfied in a weak sense for a.e. x ∈ Ω: for all τ ∈ (0, T ] and
φ ∈ C([0, 1]× [0, T ]) with ∂tφ ∈ C([0, 1]× [0, T ])∫
φ(y, τ) dgx,τ (y)−
∫
φ(y, 0) d(f0)x(y)−
∫ τ
0
(∫
∂tφ(y, t) dgx,t(y)
)
dt
=
∫ τ
0
ηχ
[∫ 1
0
φ(y, t)∂yAx(y, t)
(∫
P (t, Ax(ξ, t), Ax(y, t)) dgx,t(ξ)
)
dy−
∫
φ(y, t) dgx,t(y)
]
dt;
(26)
(vi) if 1 ≤ i < N , ui ∈ L2([0, T ];H1(Ω)) and
di
∫ T
0
[∫
Ω
∇ui(x, s)·∇ψ(x, s)dx| + γi
∫
∂Ω1
ui(x, s)ψ(x, s)dσ(x)
]
ds
= ε
∫∫
QT
ui∂tψ + ε
∫
Ω
u0iψ(x, 0) dx+
∫∫
QT
R˜iψ
(27)
for all ψ ∈ H1([0, τ ];H1(Ω)), ψ(x, τ) = 0, where R˜i is defined as in (24);
(vii) ∂tuN ∈ C(QT ), uN(·, 0) = u0N in Ω, and the equation for uN in (24) is satisfied in QT .
In the remainder of this section we prove the equivalence of problems (6)-(8) and (24)-(25).
The following result is a first step in this direction.
Theorem 3.3. Let hypotheses (H1−6) be satisfied. Let (A, g, u1, · · · , uN) be a solution of (24)-(25)
in [0, T ] and set, for a.e. x ∈ Ω,
fx,t := Ax(·, t)#gx,t for all t ∈ [0, T ].
Then (f, u1, . . . , uN) is a solution of problem (6)-(8) in [0, T ].
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Proof. Since, for a.e. x ∈ Ω, gx,t is a Borel regular probability measure in [0, 1] for t ∈ [0, T ], so is
fx,t. By (18), for a.e. x ∈ Ω the function y → Ax(y, t) is injective for t ∈ [0, T ], so that, by [16],
Theorem 1.18,
(28) supp fx,t = Ax(supp gx,t, t) ⊆ Ax([0, 1], t) = [Ax(0, t), 1].
In particular fx,t ∈ X[0,1] for a.e. x ∈ Ω. In addition, by Remark 2.3 (b) and Proposition A.10,
the map t 7→ fx,t belongs to C([0, T ];X[0,1]) for a.e. x ∈ Ω.
Let, for a.e. x ∈ Ω, v be defined by (3) and J by (5). By (28) and (11),
∫
P (t, b, a) dfx,t(b) = 0
if a < Ax(0, t), whence
(29) supp Jx,t ⊂ [Ax(0, t), 1].
To avoid cumbersome notations, we set Bx(·, t) := A−1x (·, t). Since
Ax(·, t) : [0, 1]→ [Ax(0, t), Ax(1, t)] = [Ax(0, t), 1],
Bx(·, t) is well defined in [Ax(0, t), 1], Bx(Ax(y, t), t) ≡ y for y ∈ [0, 1], and Ax(Bx(a, t), t) ≡ a for
a ∈ [Ax(0, t), 1]. Since supp fx,t ⊂ [Ax(0, t), 1], integrals of functions of B(·, t) with respect to fx,t
are well defined.
By Definition 3.2 (iv), ∂tAx(y, t) = vx(Ax(y, t), t) for a.e. x ∈ Ω. By (18), Bx is Lipschitz
continuous with respect to y for a.e. x ∈ Ω. Differentiating the identity Ax(Bx(y, t), t) = y with
respect to t and y, we obtain that
(30)
{
∂yAx(Bx(a, t), t)∂tBx(a, t) = −∂tAx(Bx(a, t), t) = −vx(Ax(Bx(a, t)), t) = −vx(a, t)
∂yAx(Bx(y, t), t)∂yBx(y, t) = 1,
so that ∂tBx(y, t)∂yAx(Bx(y, t), t)∂yBx(y, t) = ∂tBx(y, t) and, by (30),
(31) ∂tBx(y, t) = −vx(y, t)∂yBx(y, t).
Let ψ ∈ C1([0, 1]× [0, T ]). Let x be fixed such that Ax, ∂tAx ∈ C([0, T ];X[0,t]), and set
φ(y, t) = ψ(Ax(y, t), t) for y ∈ [0, 1]
and
Cφ = −
∫
φ(y, τ) dgx,τ (y) +
∫
φ(y, 0) d(f0)x(y) = −
∫
φ(Bx(a, τ), τ) dfx,τ (a) +
∫
φ(a, 0) d(f0)x(a).
Since φ satisfies the conditions in Definition 3.2(v), it follows that
−
∫ T
0
(∫
φt(y, t) dgx,t(y)
)
dt
=
∫ T
0
ηχ
[∫ 1
0
φ(y, t)∂yAx(y, t)
(∫
P (t, Ax(ξ, t), Ax(y, t)) dgx,t(ξ)
)
dy−
∫
φ(y, t) dgx,t(y)
]
dt+Cφ
=
∫ T
0
ηχ
[∫ 1
0
φ(Bx(Ax(y, t), t)∂yAx(y, t)
(∫
P (t, b, Ax(y, t)) dfx,t(b)
)
dy
−
∫
φ(Bx(Ax(y, t), t) dgx,t(y)
]
dt+ Cφ
=
∫ T
0
ηχ
[∫ Ax(1,t)
Ax(0,t)
φ(Bx(a, t), t)
(∫
P (t, b, a) dfx,t(b)
)
da−
∫
φ(Bx(Ax(y, t), t) dgx,t(y)
]
dt+Cφ,
(32)
where we have used Theorem 1.19 in [16] and the relation da = ∂yA(x, y, t) dy.
On the other hand, the left-hand side of (32) can be written as
(33) −
∫ T
0
(∫
φt(y, t) dgx,t(y)
)
dt = −
∫ T
0
(∫
φt(Bx(a, t), t) dfx,t(a)
)
dt.
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Let a ∈ [Ax(0, t), 1]. Then ψ(a, t) = φ(Bx(a, t), t) and
(34) ∂tψ(a, t) = ∂yφ(Bx(a, t), t)∂tBx(a, t) + φt(Bx(a, t), t).
Since, by (28), supp fx,t ⊆ [Ax(0, t), 1], it follows from (32)-(34) that
−
∫ T
0
(∫
∂tψ(a, t) dfx,t(a)
)
dt = −
∫ T
0
(∫
∂yφ(Bx(a, t), t)∂tBx(a, t) dfx,t(a)
)
dt
+
∫ T
0
ηχ
[∫ Ax(1,t)
Ax(0,t)
φ(Bx(a, t), t)
(∫
P (t, b, a) dfx,t(b)
)
da
−
∫
φ(Bx(a, t), t) dfx,t(a)
]
dt+ Cφ
=−
∫ T
0
(∫
∂yφ(B(x, a, t), t)∂tB(x, a, t) dfx,t(a)
)
dt
+
∫ T
0
ηχ
[∫ Ax(1,t)
Ax(0,t)
ψ(a, t)
(∫
P (t, b, a) dfx,t(b)
)
da−
∫
ψ(a, t) dfx,t(a)
]
dt+ Cφ
=−
∫ T
0
(∫
∂yφ(Bx(a, t), t)∂tBx(a, t) dfx,t(a)
)
dt+
∫ T
0
(∫
ψ(a, t) dJx,t(a)
)
dt+ Cφ.
(35)
By (31),∫
∂yφ(Bx(a, t), t)∂tBx(a, t) dfx,t(a) =
∫
∂yφ(Bx(a, t), t)∂aBx(a, t)vx(a, t) dfx,t(a)
=
∫
∂aψ(a, t)vx(a, t) dfx,t(a),
whence, by (35), the first equation in (6) is satisfied in the sense of distributions:
−
∫ T
0
(∫
∂tψ(a, t) dfx,t(a)
)
dt =
∫ T
0
(∫
∂aψ(a, t)vx(a, t) dfx,t(a)
)
dt
+
∫ T
0
(∫
ψ(a, t) dJx,t(a)
)
dt−
∫
ψ(a, τ) dfx,τ (y)+
∫
ψ(a, 0) d(f0)x(a).
Concerning the Smoluchowski system in (6), ii is enough to observe that the third equation in
(24) and the second equation in (6) coincide, since∫
(µ0 +Ax(ξ, t))(1 −Ax(ξ, t)) dgx,t(ξ) =
∫
(µ0 + a)(1− a) dfx,t(a).
Here we have used again Theorem 1.19 in [16]. 
The proof that problems (6)-(8) and (24)-(25) are equivalent is completed by the following
result.
Theorem 3.4. Let (f, u1, · · · , uN) be a solution of (6)-(8) in [0, T ] and let Ax(y, t) be defined by
(16). Then there exists a probability measure gx,t such that
fx,t := Ax(·, t)#gx,t,
and (A, g, u1, . . . , uN) is a solution of problem (24)-(25) in [0, T ].
Proof. As before we reason for a.e. x ∈ Ω. Fixing such x ∈ Ω, and also an arbitrary t ∈ [0, T ], we
consider the map
Ax(·, t) : [0, 1] 7→ [Ax(0, t), 1].
By Proposition 3.1, fx,t = fx,t [Ax(0, t), 1]. Hence, by Theorem 1.20 in [16], there exists a Radon
measure gx,t on [0, 1] such that
fx,t = fx,t [Ax(0, t), 1] = Ax(·, t)#gx,t.
Obviously gx,t is a probability measure and belongs to X[0,1]. By Corollary A.10, the map t 7→ gx,t
is continuous with respect to the Wasserstein metric. In addition, gx,t → (f0)x as t → 0 since
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Ax(y, 0) = y. Therefore g satisfies the qualitative assumptions in order to be a solution of (24)
and (25).
To complete the proof of the theorem, it is enough to check the identities in the proof of
Theorem 3.3 in the opposite direction. 
4. Local existence and uniqueness
By Theorems 3.3 and 3.4, problems (6)-(8) and (24)-(25) are equivalent. In this section we
prove local (w.r.t. t) existence and uniqueness of a solution of problem (24)-(25). In section 5 we
shall show that this solution can be continued in [0, T ], which completes the proof of the main
result, Theorem 2.4.
So in this section we have to prove:
Theorem 4.1. Let Ω ⊂ Rn be an open and bounded set with a smooth boundary ∂Ω, which is
the disjunct union of smooth manifolds ∂Ω0 and ∂Ω1. Let T > 0 and N ∈ N, and let hypotheses
(H1−6) be satisfied. Then there exists τ ∈ (0, T ] such that problem (24)-(25) has a unique solution
in [0, τ ].
The proof is based on a contraction argument. To this purpose we introduce a suitable metric
space.
Definition 4.2. Let τ ∈ (0, T ] be given. We denote by (Xτ , d) the complete metric space
Xτ := L
∞(Ω;C([0, 1]× [0, τ ]; [0, 1]))××C(Ω× [0, τ ];RN ),
where L∞(Ω;C([0, 1]× [0, τ ]; [0, 1])), and C(Ω× [0, τ ];RN) are endowed with their natural metrics
as normed spaces, and L(Ω;C([0, T ];X[0,1])) is endowed with the metric
sup
x∈Ω
max
t∈[0,T ]
W1(fx,t, gx,t)
(notice that condition (13) passes to the limit with respect to theW1-convergence, by Proposition
A.7).
We denote by Xτ,ρ the closed ball in Xτ of radius ρ > 0 centered at (y, f0, u0).
Observe that, for the moment, we have given up the nonnegativity of ui, which will be recovered
during the proof of Theorem 4.1. For this reason we define S also for negative values of ui, by
requiring that S is even with respect to ui for each i = 1, · · · , N−1.
We must construct the map to which we can apply the contraction argument. We shall do this
step by step.
Lemma 4.3. Let (Aˆ, g, u) ∈ XT and set, for a.e. x ∈ Ω,
(36) vˆx(a, t) :=
∫
Gx(a, Aˆx(ξ, t)) dgx,t(ξ) + S(x, a, u1, . . . , uN−1) ≥ 0.
Then, for a.e. x ∈ Ω, the Cauchy problem
(37)
{
∂tAx(y, t) = vˆx(Ax(y, t), t) for t > 0
Ax(y, 0) = y ∈ [0, 1]
has a unique solution defined for all t ∈ (0, T ], and the function y 7→ Ax(y, t) is continuous, strictly
increasing (and thus open) on [0, 1] and maps [0, 1] onto [Ax(0, t), 1] for all t ∈ [0, T ]. Finally, the
map (x, y, t) 7→ Ax(y, t) belongs to L
∞(Ω;C([0, 1]× [0, T ]; [0, 1]).
Proof. We claim that, for a.e. x ∈ Ω, the map (a, t) 7→ vˆx(a, t) is continuous and Lipschitz
continuous with respect to a ∈ [0, 1], uniformly in t ∈ [0, T ].
By (10) this is trivial for the map (a, t) 7→ S(x, a, u1(x, t), . . . , uN−1(x, t)), since (x, t) 7→
(u1, . . . , uN−1) is continuous on Ω× [0, T ] and (u1, . . . , uN−1) belongs to a compact set of RN−1.
It remains to show that (a, t) 7→
∫
Gx(a, Aˆx(ξ, t)) dgx,t(ξ) is continuous and uniformly Lipschitz
continuous with respect to a ∈ [0, 1].
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Let a0, a ∈ [0, 1] and t0, t ∈ (0, T ] be given. Then∣∣∣∣
∫
Gx(a, Aˆx(ξ, t)) dgx,t(ξ, t)−
∫
Gx(a0, Aˆx(ξ, t0)) dgx,t0(ξ)
∣∣∣∣
≤
∣∣∣∣
∫
Gx(a, Aˆx(ξ, t)) dgx,t(ξ) −
∫
Gx(a0, Aˆx(ξ, t0)) dgx,t(ξ, t)
∣∣∣∣
+
∣∣∣∣
∫
Gx(a0, Aˆx(ξ, t0)) dgx,t(ξ)−
∫
Gx(a0, Aˆx(ξ, t0)) dgx,t0(ξ)
∣∣∣∣ := I1 + I2.
Since (a, ξ, t) 7→ Gx(a, Aˆx(ξ, t)) is uniformly continuous in [0, 1]2×[0, T ], I1 → 0 as (a, t)→ (a0, t0).
Since ξ 7→ Gx(a0, Aˆx(ξ, t0)) is continuous in [0, 1]) and t 7→ gx,t is narrowly continuous (see
Proposition A.7), also I2 → 0 as t→ t0.
Similarly, by (9), for a.e. x ∈ Ω and all ξ ∈ [0, 1] and t ∈ [0, T ],∣∣∣Gx(a, Aˆx(ξ, t))− Gx(a′, Aˆx(ξ, t))∣∣∣ ≤ C|a− a′| for a, a′ ∈ [0, 1].
This completes the proof of the claim, which implies, for a.e. x ∈ Ω, the existence and uniqueness
of the solution problem (37) for all y ∈ [0, 1]. By a standard argument,
(38) ∂yAx(y, t) = exp
[∫ t
0
∂avˆx(Ax(y, s), s)ds
]
> 0,
so 0 < C1 ≤ ∂yAx(y, t) ≤ C2 for some constants C1 and C2 which depend on the compact set
K ⊂ RN−1 which contains (u1(x, t), . . . , uN−1(x, t)). 
Remark 4.4. It follows from the proof of Lemma 4.3 (in particular from (38)) that Ax(ξ, s) is
Lipschitz continuous in ξ, uniformly with respect to x and s.
Lemma 4.5. Let (Aˆ, g, u) ∈ XT . Let, for a.e. x ∈ Ω, A be defined as in Lemma 4.3 and (F [g])x,t
be the signed measure on [0, 1] defined by
d(F [g])x,t=η(t)χ(x, t)
[
∂yAx(y, t)
∫
P (t, Ax(ξ, t), Ax(y, t))dgx,t(ξ) dy − dgx,t(y)
]
for 0 < t ≤ T . Then, for a.e. x ∈ Ω,
(i) the integral equation
(39) g
x,t
= (f0)x +
∫ t
0
(F [g])x,s ds
has a unique solution t 7→ g
x,t
which belongs to C([0, T ], X[0,1]);
1
(ii) the measure g
x,t
is a weak solution of the system

∂tgx,t(y) = ηχ
[
∂yAx(y, t)
∫
P (t, Ax(ξ, t), Ax(y, t))dgx,t(ξ) − gx,t(y)
]
g
x,0
= (f0)x
in the sense of (26).
Proof. First of all, we observe that for a.e. x ∈ Ω and s ∈ [0, T ] and for all g ∈ X[0,1],
(40)
∫
d(F [g])x,s = 0.
1If t→ µ(t) is a continuous map from [0, T ] to X[0,1], for any Borel set B ⊂ [0, 1], we set
(∫ t
0
µ(s) ds
)
(B) :=
∫
t
0
µ(s)(B) ds.
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The assertion is obvious if χ(x, s) = 0. If χ(x, s) = 1, by Tonelli’s theorem,
1
η
∫
d(F [g])x,s =
∫ (∫
P (s, Ax(ξ, s), Ax(y, s))∂yAx(y, s))dy
)
dgx,s(ξ)−
∫
dgx,s(y)
=
∫ (∫
P (s, Ax(ξ, s), b)db
)
dgx,s(ξ)−
∫
dgx,s(y) = 0.
We set, for a.e. x ∈ Ω (from now on we fix such x),
qt := e
∫
t
0
η(s)χ(x,s)dsgx,t for t ∈ [0, T ].
Let Y be the set of such q, i.e. q ∈ Y if the map t 7→ e−
∫
t
0
η(s)χ(x,s)dsqt belongs to C([0, T ], X[0,1]).
Then Y naturally inherits a metric from C([0, T ], X[0,1]),
dY (q1, q2) := sup
t∈(0,T )
W1
(
e−
∫
t
0
η(s)χ(x,s)ds(q1)t, e
−
∫
t
0
η(s)χ(x,s)ds(q2)t
)
,
so Y is a complete metric space.
The equation for g translates into
∂tqt(y) = Lqt(y) :=ηχ(x, t)∂yAx(y, t)
∫
P (t, Ax(ξ, t), Ax(y, t))dqt(ξ) ≥ 0,
and the corresponding integral equation is
(41) qt = (f0)x +
∫ t
0
Lqs ds for t ∈ [0, T ].
We consider the map
(42) q 7→ (f0)x +
∫ t
0
Lqs ds.
One easily checks that, by (40), for all q ∈ Y
(43)
∫
dLqt = 0 for t ∈ [0, T ], (f0)x +
∫ t
0
Lqs ds ∈ Y.
If we show that for all q1, q2 ∈ Y
(44) J0(q1, q2) := dY
(
(f0)x +
∫ t
0
L(q1)s, (f0)x +
∫ t
0
L(q2)s
)
≤ CdY (q1, q2),
it follows from a standard contraction argument that the map (42) has a unique fixed point in a
sufficiently small interval [0, τ ] and that equation (41) has a unique local solution q which can be
continued in [0, T ].
To prove (44) we use the characterisation of the W1-distance given in Proposition A.4:
(45) dY (q1, q2) = sup
t∈(0,T )
[
e−
∫
t
0
η(s)χ(x,s)ds sup
{∫
φd(q1 − q2)t ; φ ∈ Lip1([0, 1],R)
}]
.
Hence
J0(q1, q2) = sup
t∈(0,T )
[
e−
∫
t
0
η(s)χ(x,s)ds sup {Iφ(t) ; φ ∈ Lip1([0, 1],R)}
]
,
where
Iφ(t) :=
∫
φd
∫ t
0
(L(q1)s − L(q2)s) ds
and L(q1)s − L(q2)s is given by
η(s)χ(x, s)
(∫
P (s, Ax(ξ, s), Ax(y, s))∂yAx(y, s)d(q1 − q2)s(ξ)
)
dy.
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By Tonelli’s Theorem, Iφ(t) is equal to∫
φ(y)
∫ t
0
(
ηχ
(∫
P (s, Ax(ξ, s), Ax(y, s))∂yAx(y, s)d(q1 − q2)s(ξ)
)
dy
)
ds
=
∫ t
0
ηχ
(∫ 1
Ax(0,s)
φ(Bx(b, s))
(∫
P (s, Ax(ξ, s), b)d(q1 − q2)s(ξ)
)
db
)
ds
=
∫ t
0
ηχ
(∫ (∫ 1
Ax(0,s)
φ(Bx(b, s))P (s, Ax(ξ, s), b)db
)
d(q1 − q2)s(ξ)
)
ds.
By (43), Iφ(t) = 0 if φ is constant, so we may assume that φ(0) = 0. Hence |φ| ≤ 1 and, by (12),∣∣∣∣∣
∫ 1
Ax(0,s)
φ(Bx(b, s)) (P (s, Ax(ξ
′, s), b)− P (s, Ax(ξ
′′, s), b)) db
∣∣∣∣∣
≤
∫ 1
A(x,0,s)
|P (s, Ax(ξ
′, s), b)− P (s, Ax(ξ
′′, s), b)| db ≤ L|ξ′ − ξ′′|.
Now (44) follows from (45):
J0(q1, q2) ≤ TL max
t∈[0,T ]
η(t) dY (q1, q2).
Setting
g
x,t
= e−
∫
t
0
η(s)χ(x,s)dsq
t
for t ∈ [0, T ],
we have completed the proof of part (i) of the lemma.
Fix an x ∈ Ω for which (39) and (41) (for q) are valid. Since P and Ax are continuous functions
and the map t 7→ g
x,t
is continuous in the weak∗ topology (and so is t 7→ q
t
), the map
(y, t) 7→
∫
P (t, Ax(ξ, t), Ax(y, t))dqt(ξ)
is continuous in [0, 1]× [0, T ]. Hence L(q, ·) ∈ L∞((0, 1)× (0, T )).
We set q˜ = q − (f0)x. By (41)
q˜t =
∫ t
0
L(q˜s + (f0)x) ds for t ∈ [0, T ].
Since, by the boundedness of L(q˜s + (f0)x)(y), t 7→ q˜t(y) is absolutely continuous in [0, T ] for
a.e. y ∈ (0, 1), this means that
(46)
∫ 1
0
ψ(y, τ)q˜τ (y)dy =
∫∫
(0,1)×(0,τ)
[ψt(y, t)q˜t(y)+ψ(y, t)L((q˜t−(f0)x)(y))] dydt
for all τ ∈ (0, T ] and ψ ∈ L∞([0, 1]× [0, T ]) with ψt ∈ L∞([0, 1]× [0, T ]).
Finally let φ(y, t) be as in the first part of the proof (we recall that x is fixed). We substitute
the function ψ(y, t) = e−
∫
t
0
η(s)χ(x,s)dsφ(y, t) into (46). Since
∂tψ(y, t) = e
−
∫
t
0
η(s)χ(x,s)ds(−ηχφ(y, t) + ∂tφ(x, y, t),
ψ and ∂tψ are continuous with respect to y and, by a straightforward calculation, (46) transforms
into
(47)
∫
φ(y, τ)dg
x,τ
(y)−
∫
ψ(y, 0)d(f0)x(y) = −
∫ τ
0
[∫
∂tψ(y, t)d(f0)x(y)
]
dt
+
∫ τ
0
(∫
φ(y, t)d(F [g])x,t(y) +
∫
∂tφ(y, t))dgx,t(y)
)
dt
for all τ ∈ (0, T ]. Since ψ(y, 0) = φ(y, 0), this implies that g
x,t
(y) satisfies the equation of the
system in the sense of (26):∫
φ(y, τ)dg
x,τ
(y)−
∫
φ(y, 0)d(f0)x(y) =
∫ τ
0
(∫
φ(y, t)d(F [g])x,t(y) +
∫
∂tφ(y, t))dgx,t(y)
)
dt.
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
Let (Aˆ, g, u) := (Aˆ, g, u1. . . . , uN ) ∈ Xτ,ρ. By Lemma 4.3, (Aˆ, g, u) uniquely defines a func-
tion A ∈ L∞(Ω;C([0, 1] × [0, τ ]; [0, 1]), and, by Lemma 4.5, A uniquely defines a measure g ∈
L(Ω;C([0, T ];X[0,1])). Let u := (u1, . . . , uN) be the weak solution of the problem
(48)
{
ε∂tum − dm∆um = Fm(A, g, u) (1 ≤ m < N)
ε∂tuN = FN (A, g, u),
in Qτ = Ω× (0, τ ]
with initial-boundary conditions
(49)


ui(x, 0) = u0i(x) if x ∈ Ω
∂nui(x, t) = 0 if x ∈ ∂Ω0, t > 0
∂nui(x, t) = −γiui(x, t) if x ∈ ∂Ω1 × (0, τ ]
(1 ≤ i ≤ N).
Here we have set

F1(A, g, u) :=−σ1u1−u1
N∑
j=1
a1,juj+CF
∫ 1
0
(µ0+Ax(ξ, t))(1−Ax(ξ, t))dgx,t(ξ)
Fm(A, g, u) :=−σmum +
1
2
m−1∑
j=1
aj,m−jujum−j − um
N∑
j=1
am,juj
FN (A, g, u) :=
1
2
∑
j+k≥N
k, j<N
aj,kujuk.
Observe that Fi ∈ L∞(Ω×[0, τ ]) (i = 1, . . . , N) and its norm only depends on the compact setK ⊂
R
n containing (u1, · · · , uN ). We also observe that system (48)-(49) consists of N − 1 (uncoupled)
scalar linear heat equations with linear boundary conditions and an ordinary differential equation.
Therefore it has a unique weak solution u. More precisely, following [17] and recalling that Xτ,ρ
denotes the closed ball of radius ρ > 0 centered at (y, f0, u0) in Xτ , we have that
Proposition 4.6 ([17], Theorems 2.11, 3.2 and 3.3). Let (Aˆ, g, u) ∈ Xτ,ρ. For all 1 ≤ i < N there
exists a unique ui ∈ C([0, τ ];L
2(Ω)) ∩ L2([0, τ ];H1(Ω)) such that∫ τ
0
[∫
Ω
∇ui(x, s) · ∇ψ(x, s) dx + γi
∫
∂Ω1
ui(x, s)ψ(x, s) dσ(x)
]
ds
=
∫∫
Qτ
ui∂tψ +
∫
Ω
u0iψ(x, 0) dx+
∫∫
Qτ
Fi(A, g, u)ψ
for all ψ ∈ H1([0, τ ];H1(Ω)), ψ(x, τ) = 0. Let uN (x, t) = u0N (x) +
∫ τ
0
FN (A, g, u) ds and u =
(u1, · · · , uN ). Then u ∈ C(Qτ ;R
N ), u(·, 0) = u0 and, for 1 ≤ i ≤ N ,
‖ui‖C(Qτ ;R) ≤ C
{
‖u0i‖L∞(Ω) + ‖Fi‖Lr(Qτ ;R)
}
if r > n, 1
r
+ n2r < 1.
In particular ‖ui‖C(Qτ ;R) ≤ C
{
‖u0i‖C(Ω) + ‖Fi‖C(Qτ ;R)
}
.
Now we are ready to define the map to which we shall apply a contraction argument. Let ρ > 0
be fixed. Using the notation A (Lemma 4.3), g (Lemma 4.5) and u (Proposition 4.6) introduced
above, we set
(50) H(Aˆ, g, u) := (A, g, u) for (Aˆ, g, u) ∈ Xτ,ρ.
Let Td denote the metric topology of Xτ,ρ and T the weaker topology on Xτ,ρ which is obtained
by endowing L∞(Ω;C([0, 1]× [0, τ ]; [0, 1])) with the L1-topology on Ω× [0, 1]× [0, τ ].
Proposition 4.7. Let ρ > 0 be fixed and let H(Aˆ, g, u) be defined by (50). If τ > 0 is sufficiently
small, then H : Xτ,ρ → Xτ,ρ, (An, gn, un) → (A, g, u) in T if (Aˆn, gn, un) → (Aˆ, g, u) in Td, and
H is a contraction on H(Xτ,ρ).
16 M. BERTSCH, B. FRANCHI, M. C. TESI, AND A. TOSIN
Proof. First we prove that H(Xτ,ρ) ⊂ Xτ,ρ if τ is sufficiently small.
By Proposition 4.6, ‖u(·, t)−u0‖C(Ω;RN )→ 0 as t→ 0
+, so it remains to show that, as t→ 0+,
(51) sup
x∈Ω, 0≤y≤1
|Ax(y, t)− y| → 0, sup
x∈Ω
‖g
x,t
− (f0)x‖X[0,1] → 0.
Since, by (37) and assumptions (9) and (10),
|Ax(y, t)− y| ≤
∫ τ
0
{∫
Gx(Ax(y, s), Aˆx(ξ, s)) dgx,s(ξ) + S(x,Ax(y, s), u(x, s))
}
ds
≤ C1
∫ τ
0
|Ax(y, s)− y| ds+ C2τ,
(51)1 follows from Gronwall’s Lemma. On the other hand, (51)2 easily follows from Lemma 4.5(i)
and its proof.
To prove the (Td, T )-continuity of H, let Aˆn, Aˆ ∈ L∞(Ω;C([0, 1] × [0, τ ]; [0, 1]) be such that
(Aˆn, gn, un)→ (Aˆ, g, u) in Xτ,ρ as n→∞. We must show that An → A in L1(Ω× [0, 1]× [0, τ ]).
By the Dominated Convergence Theorem, this follows if
(52) An → A a.e. in Ω× [0, 1]× [0, τ ] as n→∞.
To prove (52) we observe that
|(An)x(y, t)−Ax(y, t)|
≤
∫ t
0
∣∣∣∣
∫ [
Gx((An)x(y, s), (Aˆn)x(ξ, s)) − Gx(Ax(y, s), Aˆx(ξ, s))
]
d(gn)x,s(ξ)
∣∣∣∣ds
+
∫ t
0
∣∣∣∣
∫
Gx(Ax(y, s), Aˆx(ξ, s))d(gn − g)x,s(ξ)
∣∣∣∣ ds
+
∫ t
0
|S(x, (An)x(y, s), un(x, s)) − S(x, (An)x(y, s), u(x, s))| ds
+
∫ t
0
|S(x, (An)x(y, s), u(x, s))− S(x,Ax(y, s), u(x, s))| ds
=: I1 + I2 + I3 + I4,
(53)
where Ij = Ij(x, y, t) for j = 1, 2, 3, 4. It follows easily from (10) that
I3 ≤ Cρt sup
x∈Ω,0≤s≤τ
|un(x, s)− u(x, s)| ≤ Cρt d((Aˆn, gn, un), (A, g, u)),
I4 ≤ Cρt sup
x∈Ω, 0≤y≤1, 0≤s≤τ
|(Aˆn)x(y, s))−Aˆx(y, s)|≤Cρt d((Aˆn, gn, un), (A, g, u)).
By (9),
I1 ≤Cρ
∫ t
0
{∫ ∣∣(An)x(y, s)−Ax(y, s)∣∣d(gn)x,s(ξ)} ds
+ Cρ
∫ t
0
{∫ ∣∣(Aˆn)x(ξ, s)) − Aˆx(ξ, s))∣∣d(gn)x,s(ξ)} ds
=Cρ
∫ t
0
∣∣(An)x(y, s)−Ax(y, s)∣∣ ds
+ Cρ
∫ t
0
{∫ ∣∣(Aˆn)x(ξ, s)) − Aˆx(ξ, s))∣∣d(gn)x,t(ξ)} ds
≤Cρ
∫ t
0
∣∣(An)x(y, s)−Ax(y, s)∣∣ ds+ Cρt d((Aˆn, gn, un), (A, g, u)).
Thus, by Gronwall’s inequality, Proposition A.7 and the Dominated Convergence Theorem,∣∣∣(An)x(y, t)−Ax(y, t)∣∣∣ ≤ I2(x, y, τ) + Cρτ d((Aˆn, gn, un), (A, g, u))→ 0(54)
as n→∞. This proves (52).
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It remains to prove that H is a contraction on H(Xρ,τ ) if τ is small enough. Let (Aˆ1, g1, u1),
(Aˆ2, g2, u2) ∈ Xρ,τ . Repeating verbatim the arguments leading to (54), we obtain that∣∣[A1x −A2x](y, t)∣∣ ≤
∫ t
0
∣∣∣∣
∫
Gx(A
2
x(y, s), Aˆ
2
x(ξ, s))d(g
1 − g2)x,s(ξ)
∣∣∣∣ ds
+Cρτ d((Aˆ
1, g1, u1), (Aˆ2, g2, u2)).
(55)
Since (Aˆ2, g2, u2) ∈ H(Xρ,τ ), it follows from Remark 4.4 that Aˆ
2
x(ξ, s) and, by (9),
Gx(A
2
x(y, s), Aˆ
2
x(ξ, s)) are Lipschitz continuous in ξ, uniformly with respect to x and s. Thus, by
Proposition A.4,∣∣A1x(y, t)−A2x(y, t)∣∣ ≤ Cρ
∫ t
0
W(g1x,s, g
2
x,s) ds ≤ Cρτ d((Aˆ
1, g1, u1), (A2, g2, u2)).(56)
Consider now W1(g1x,t, g
2
x,t
). In view of the definition of g1, g2, we may repeat verbatim the
arguments in the proof of Lemma 4.5 and obtain that
W1(g
1
x,t
, g2
x,t
) ≤ Cmax
[0,T ]
η t sup
0≤s≤t
W1
(
g1x,s, g
2
x,s
)
≤ Cτ d((Aˆ1, g1, u1), (Aˆ2, g2, u2)).
(57)
Finally, we estimate sup
Ω×[0,τ ]
|u1 − u2|. Set U = u1 − u2 and U = (U1, . . . , UN ). Then U is a
weak solution (in the sense of Proposition 4.6) of a system similar to (48)-(49), with Fj replaced
by F˜j := Fj(A
1, g1, u1)− Fj(A
2, g2, u2), j = 1, . . . , N , and u0 by U(x, 0) = 0. By Proposition 4.6,
‖U‖C(Ω×[0,τ ];R) ≤ C
N∑
i=1
‖F˜i‖C(Ω×[0,τ ];R).(58)
If k > 1, Fk is a polynomial in the components of u and, since u1, u2 are uniformly bounded by ρ
in Ω× [0, τ ],
(59) ‖F˜k‖C(Ω×[0,τ ];R) ≤ Cρ
∑
i
‖u1i − u
2
i ‖C(Ω×[0,τ ];R) if k > 1.
The same argument applies to the polynomial terms of F˜1, so we are left with the estimate of
I=
∥∥∥∥
∫ 1
0
(µ0+A
1
x(ξ, t))(1−A
1
x(ξ, t)) dg
1
x,t
(ξ)−
∫ 1
0
(µ0+A
2
x(ξ, t))(1−A
2
x(ξ, t)) dg
2
x,t
(ξ)
∥∥∥∥
C(Ω×[0,τ ];R)
.
Arguing as above,
I ≤ J1 + J2 :=
∫ 1
0
∣∣(µ0 +A1x(ξ, t))(1 −A1x(ξ, t))− (µ0 +A2x(ξ, t))(1 −A2x(ξ, t))∣∣ dg1x,t(ξ)
+
∣∣∣ ∫ 1
0
(µ0 +A
2
x(ξ, t))(1 −A
2
x(ξ, t)) d(g
1 − g2)(ξ)
∣∣∣.
Repeating the arguments that yield the estimate (55), we have that
J1 ≤ Cρ sup
x,ξ,t
∣∣A1x(ξ, t)) −A2x(ξ, t))∣∣
∫ 1
0
dg1
x,t
(ξ)
= Cρ sup
x,ξ,t
∣∣A1x(ξ, t)) −A2x(ξ, t))∣∣ ≤ Cρτ d((Aˆ1, g1, u1), (A2, g2, u2)).
Concerning J2, by Remark 4.4 the map ξ → (µ0 + A
2
x(ξ, t))(1 − A
2
x(ξ, t)) is uniformly Lipschitz
continuous. Thus, by Proposition A.4 and (57),
J2 ≤ CρW1(g
1, g2) ≤ Cρτ d((Aˆ
1, g1, u1), (Aˆ2, g2, u2)).
Combining the estimates of I, J1, J2 with (59) and (58), we obtain that
(60) ‖u1 − u2‖C(Ω×[0,τ ];R) ≤ Cρτ d((Aˆ
1, g1, u1), (Aˆ2, g2, u2)).
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It follows from (56), (57) and (60) that H is a contraction on H(Xρ,τ ) if τ is small enough. 
To complete the proof of Theorem 4.1, we need a minor modification of the classical Banach-
Caccioppoli fixed point theorem:
Proposition 4.8 (Fixed Point Theorem). Let (X, d) be a complete metric space and let Td be the
topology induced by d. Let T be a Hausdorff topology on X which is weaker than Td. If H : X → X
is a contraction on H(X) which is (Td, T )-continuous, then H has a unique fixed point.
Proof. We start carrying out the standard iteration procedure
(61) xn+1 = H(xn),
starting from a point x0 ∈ H(X), so that xn ∈ H(X) for all n ≥ 0. As usual, by the completeness
of (X, d), we may assume that xn → x¯ ∈ X as n → ∞. When H is a contraction on all of X
(and hence in particular is Lipschitz continuous from X to X) we can conclude the proof taking
the limit as n → ∞ in (61). In our case the argument has to be slightly adapted: on one side,
xn+1 → x¯ as n → ∞ with respect to the topology T (since it is weaker that Td), on the other
hand H(xn) → H(x¯) as n → ∞ with respect to the topology T , since H is (Td, T )-continuous,
Thus, by (61) we can conclude that x¯ = H(x¯) by the uniqueness of the limit in T . 
Proof of Theorem 4.1. By Proposition 4.7 and the Fixed Point Theorem, system (24)-(25) has a
unique solution (in the sense of Definition 3.2) in [0, τ ] for sufficiently small values of τ if we show
the nonnegativity of ui:
(62) ui ≥ 0 in Ω× [0, τ ] (i = 1, . . . , N).
If i = N , (62) is trivially satisfied. If 1 ≤ i < N , (62) formally follows from the maximum principle.
Below we make this precise if i = 1. If i > 1 the proof is even easier.
Since f = CF
∫ 1
0
(µ0 + Aˆx(ξ, t))(1 − Aˆx(ξ, t)) dgx,t(ξ) is nonnegative and belongs to L∞(QT ),
there exists a sequence of smooth nonnegative functions (fk)k∈N converging to f in L
r(QT ), where
r > n and 1
r
+ n2r < 1. We also approximate h =
∑N
j=1 a1,juj ∈ C(QT ) uniformly by smooth
functions hk. Let vk be the unique smooth solution of
(63)


ε∂tvk = d1∆vk − vkhk + fk in Qτ
vk(x, 0) = u01(x) if x ∈ Ω
∂nvk(x, t) = 0 if x ∈ ∂Ω0, t > 0
∂nvk(x, t) = −γivk(x, t) if x ∈ ∂Ω1, t > 0.
Since γ1 > 0, fk ≥ 0 in Qτ and u01 ≥ 0 in Ω, it follows from the maximum principle that vk ≥ in
Qτ .
On the other hand wk := u1 − vk is a weak solution of
(64)


ε∂twk = d1∆wk − wkhk + f − fk in Qτ
wk(x, 0) = 0 if x ∈ Ω
∂nwk(x, t) = 0 if x ∈ ∂Ω0, t > 0
∂nwk(x, t) = −γiwk(x, t) if x ∈ ∂Ω1, t > 0,
and it follows from [17], Theorem 3.2, that vk → u1 uniformly on Qτ . Therefore also u1 ≥ 0 in
Qτ . 
5. Global existence
In this section we complete the proof of Theorem 2.4 by showing that the local solution of
problem (24)-(25), constructed in the previous section, can be continued to the whole interval
[0, T ]. We recall that problems (24)-(25) and (6)-(8) are equivalent, as we have shown in section
3.
Arguing by contradiction we suppose that the maximal interval of existence is [0, τ∗) for some
τ∗ < T .
A MODEL FOR ALZHEIMER’S DISEASE 19
A priori estimate for u(x, t). Since
(65) CF
∫ 1
0
(µ0 +Ax(ξ, t))(1 − Aˆx(ξ, t)) dgx,t(ξ) ≤ C1 in Ω× [0, τ
∗)
for some constant C1, it follows formally from the maximum principle that
u1(x, t) ≤ sup
Ω
u01 + C1t for x ∈ Ω, 0 ≤ t < τ
∗.
Similarly, if u1, · · · , um−1 are bounded in L∞(Ω× [0, τ∗)) for some 1 < m < N , then
1
2
m−1∑
j=1
aj,m−jujum−j ≤ Cm in Ω× [0, τ
∗)
for some constant Cm, and it follows formally from the maximum principle that
um(x, t) ≤ sup
Ω
u0m + Cmt for x ∈ Ω, 0 ≤ t < τ
∗.
In both cases the use of the maximum principle is justified as in the proof of (62).
The boundedness of uN in Ω× [0, τ∗) follows from that of u1, · · · , uN−1, so we have shown that,
for some Cu > 0,
(66) |u| ≤ Cu in Ω× [0, τ
∗).
Existence of limt→τ∗ Ax(y, t) =: Ax(y, τ
∗). Arguing as in the proof of Lemma 4.3 we obtain that
Ax(y, t) and vx(Ax(y, t), t) are Lipschitz continuous with respect to y, uniformly with respect to
x ∈ Ω and t ∈ [0, τ∗). By the boundedness of vx(Ax(y, t), t), the map t 7→ Ax(y, t) is Lipschitz
continuous on [0, τ∗). Hence Ax(y, τ
∗) := limt→τ∗ Ax(y, t) exists and is Lipschitz continuous with
respect to y, uniformly with respect to x ∈ Ω.
Existence of limt→τ∗ gx,t =: gx,τ∗. We repeat verbatim the arguments of the proof of Lemma
4.5 and we obtain that the map t 7→ gx,t is Lipschitz continuous from [0, τ∗) to X[0,1] endowed
with Wasserstein metric W1.
Existence of limt→τ∗ u(x, t) =: u(x, τ
∗). In view of (65) and (66), it follows from standard
regularity theory for weak solutions of parabolic equations (see e.g. [20, Theorem 1, page 111])
that u is uniformly (Ho¨lder) continuous in Ω× [0, τ∗). Hence u can be extended to Ω× [0, τ∗] as
a continuous function.
Hence we can apply the local existence theorem to the “initial” functions gx,τ∗ and u(x, τ
∗),
and obtain a solution in [τ∗, τ1] for some τ1 ∈ [τ
∗, T ]. Therefore [0, τ∗) is not the maximal interval
of existence and we have found a contradiction.
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Appendix A. Probability measures and Wasserstein metrics
Throughout this appendix, X denotes a complete separable metric space, with metric d. A
positive Borel measure µ on X such that µ(X) = 1 is said a probability measure, and we write
µ ∈ P(X). Every µ ∈ P(X) is a Radon measure (see [2]).
Definition A.1 (Push forward of measures). Let B(X) be the Borel σ-algebra of subsets of X and
φ : X → X a Borel measurable function, i.e. one such that φ−1(E) ∈ B(X) for every E ∈ B(X).
Let moreover µ ∈ P(X). The push forward of µ through φ is the measure ν ∈ P(X), denoted by
ν = φ#µ, such that
ν(E) := µ(φ−1(E)), ∀E ∈ B(X).
Equivalently, the measure ν can be characterised by∫
X
f(x) dν(x) =
∫
X
f(φ(x)) dµ(x)
for every bounded Borel function f defined on X .
Definition A.2 (Wasserstein distances). Let p ≥ 1 and µ, ν ∈ P(X) be such that∫
X
d(x, x¯)p dµ(x) < +∞,
∫
X
d(x, x¯)p dν(x) < +∞
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for some x¯ ∈ X . The p-th Wasserstein distance between µ and ν is the number denoted by
Wp(µ, ν) and defined by
Wpp (µ, ν) := inf
{∫∫
X2
d(x, y)p dγ(x, y) : γ ∈ Γ(µ, ν)
}
,
where Γ(µ, ν) ⊂ P(X2) is the set of all transference plans between µ and ν, i.e. the set of measures
γ ∈ P(X2) whose marginals are µ, ν, respectively.
Proposition A.3 ([2], Proposition 7.1.5). If µ ∈ P(X) has compact support then for any x¯ ∈ X
and p ≥ 1 ∫
X
d(x, x¯)p dµ(x) < +∞.
In particular, µ has finite p-moment. We shall write µ ∈ Pp(X). Endowed with the Wasserstein
p-distance Wp, Pp(X) is a complete metric space.
Proposition A.4 (Kantorovich-Rubinstein duality, cf. [2], Eq. (7.1.2)). If µ, ν ∈ P1(X) have
compact support, then
W1(µ, ν) = sup
{∫
X
φd(µ − ν) : φ ∈ Lip1(X,R)
}
,
where Lip1(X,R) is the space of Lipschitz continuous functions φ : X → R with Lipschitz constant
not greater than 1.
Definition A.5. Let (µn)n∈N be a sequence in P(X). We say that
(i) µn → µ narrowly if for any bounded continuous function f∫
X
f dµn →
∫
X
f dµ as n→∞
(ii) µn → µ weakly
∗ if for any compactly supported continuous function f∫
X
f dµn →
∫
X
f dµ as n→∞.
Remark A.6. Obviously, narrow convergence implies weak∗ convergence, and narrow and weak∗
convergence are equivalent if X is compact.
Proposition A.7. Let X be a separable metric space. Let (µn)n∈N be a sequence in Pp(X). We
have:
(i) if Wp(µn, µ)→ 0 as n→∞, then µn → µ as n→∞ weakly
∗;
(ii) suppose there exist a compact set K such that supp µn ⊂ K for all n ∈ N and an open set O
satisfying
K ⊂ O and X \ O 6= ∅.
Then
Wp(µn, µ)→ 0 as n→∞
if and only if µn → µ as n→∞ weakly
∗ (or, equivalently, narrowly).
Proof. We apply [2, Proposition 7.1.5]. We have but to prove that the µn’s have uniformly
integrable p-moments. By [2, Lemma 5.1.7] the assertion will follow by showing that
lim
n→∞
∫
X
f(x) dµn(x) =
∫
X
f(x) dµ(x)
for any continuous real function f such that
(67) |f(x)| ≤ A+ Bd(x, x¯)p A,B > 0, x¯ ∈ X fixed.
Take now a continuous map f : X → R satisfying (67). By Urysohn’s lemma we can easily
construct a continuous function f˜ such that
supp f˜ ⊂ O and f˜ ≡ f in K.
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Thus
lim
n→∞
∫
X
f(x) dµn(x) = lim
n→∞
∫
K
f(x) dµn(x) = lim
n→∞
∫
K
f˜(x) dµn(x)
= lim
n→∞
∫
X
f˜(x) dµn(x) =
∫
X
f˜(x) dµ(x) =
∫
K
f˜(x) dµ(x)
=
∫
K
f(x) dµ(x) =
∫
X
f(x) dµ(x). 
Remark A.8. If X is compact, then the assertion is trivial. Indeed, we have already pointed out
that narrow convergence and weak∗ convergence are equivalent on compact metric spaces. Thus
we can apply [2, Proposition 7.1.5]. Indeed the µn’s have uniformly integrable p-moments, by [2,
Lemma 5.1.7].
Proposition A.9. Let X,Y be complete separable metric spaces. In addition, let X be compact
and assume that for any compact set K ⊂ Y there exists an open set O such that
K ⊂ O and Y \ O 6= ∅.
Let (µn)n∈N be a sequence in Pp(X). Let Φn : X → Y be a sequence of continuous injective
(and hence open) maps that converges uniformly to a continuous injective (and hence open) map
Φ : X → Y . Then, if p > 0
lim
n→∞
Wp(µn, µ) = 0 if and only if lim
n→∞
Wp((Φn)#µn,Φ#µ) = 0.
Proof. By Proposition A.7 and [2, Remark 5.1.5], the sequence (µn)n∈N is tight. By [2, Lemma
5.2.1]
lim
n→∞
Wp(µn, µ) = 0 ⇒ (Φn)#µn → Φ#µ
narrowly as n→∞. Set set
K0 := {y ; d(y,Φ(K)) < ε}.
If n > n¯, then supp (Φn)#µn ⊂ Φn(K) ⊂ K0 that is compact. By assumption, there is an open
set O0 such that
K0 ⊂ O0 and Y \ O0 6= ∅.
Thus, by Proposition A.7, limn→∞Wp((Φn)#µn,Φ#µ) = 0. This proves the first part of the
statement.
Suppose now limn→∞Wp((Φn)#µn,Φ#µ) = 0.
We notice now that the sequence (µn)n∈N in P(X) is tight (again by Remark A.6), and hence,
by [2, Theorem 5.1.3], is relatively compact with respect to the narrow convergence. There-
fore, there exists a subsequence (µnj )j∈N converging narrowly to ν ∈ P(X). By Proposition
A.7 limj→∞Wp(µnj , ν) = 0, and then limn→∞Wp((Φnj )#µn,Φ#ν) = 0 (by the first part of the
present proposition). Thus the uniqueness of the Wasserstein limit yields Φ#ν = Φ#µ and even-
tually ν = µ, i.e. limj→∞Wp(µnj , µ) = 0. A standard argument in metric spaces makes possible
to recover the limit for the full sequence (µn)n∈N. 
Corollary A.10. Let X, Y be complete separable metric spaces satisfying the assumption of
Proposition A.9. If I ⊂ R is an interval, let Φ : X × I → Y be a continuous map such that
for any t ∈ I the map x→ Φ(x, t) is injective and open.
If t ∈ I, let µ(t) ∈ P(X) such that suppµ(t) ⊂ K for all t ∈ I, where K ⊂ X is a compact as
in Proposition A.7.
Then t 7→ µ(t) is continuous (with respect to the Wasserstein topology) if and only if t 7→
Φ(·, t)#µ(t) is continuous (with respect to the Wasserstein topology).
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